Barely Significant

Excerpts

514,629 sentences

an increasing trendP = 0.0350.7× alphagold
In addition, Lin et al ., observed that, among maintenance hemodialysis patients, the GSTM 1 null genotype was associated with a significantly lower antioxidant capacity than the GSTM+ genotype.[ 20 ] The null/low polymorphisms of the GSTM 1 and GSTT 1 genes have been associated with the risk of developing ESRD in North Indian patients.[ 17 ] In addition, Singh et al ., reported that patients with transplant therapy demonstrated an increasing trend toward carrying the GSTM 1 null genotype (51.3%) versus healthy controls (40.4%) with a risk of about 1.5-fold ( P = 0.035), and patients with a variant genotype of GSTM 1 were at the higher risk of transplant rejection.[ 21 ] The frequencies of important functional mutations and alleles result in broad ethnic variation.
only marginally significantp = 0.03510.7× alphagold
Those without showed only marginally significant global cognition impairment (SMD = −0.3424, p = 0.0351). 3.4 Publication Bias and Sensitivity Analysis In the disease‐cognitive impairment correlation analysis, the funnel plot (Figure S6 ) and Egger's test explicitly confirmed significant publication bias ( P = 0.017).
possibly significantP = 0.03510.7× alphagold
Subgroup Analysis Subgroup analysis of the λ ex 436-nm dataset for location (fovea, perifovea, and near-periphery), age (young and aged eyes), and sex showed only one possibly significant difference in spectral peaks: between age groups in the near-periphery for peak S3 (643 nm for young eyes, 635 nm for aged eyes, P = 0.0351, t -test).
highly significantP = 0.0354710.7× alphaqualifiedgold
The results showed that there was a highly significant statistical correlation (T = -2.11459, P = 0.035471, two-tailed) with the spheroid echinates from the Sabal minor palmetto, ruling out the possibility that they were from the Washingtonia filifera palm (See S1 File ).
highly significantP=0.03590.7× alphaqualifiedgold
In contrast, the aggregated OS-12 of celecoxib in combination with TKIs or radiotherapy showed no significant improvement (P=0.1, P=0.13), with a highly significant difference between radiotherapy and chemotherapy or TKIs (67% vs 39%, P=0.0359 or 67% vs 35%, P=0.0321) and with no significant difference between chemotherapy and TKIs in terms of one-year survival (39% vs 35%, P=0.5751).